According to the latest report by IMARC Group, titled “Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, “The global enteric disease testing market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.57% during 2022-2027.
Enteric disease is an intestinal illness caused by microorganisms, such as bacteria, viruses, and parasites,which enter the body through the mouth. Its common symptoms include nausea, vomiting, abdominal cramps and anorexia that can result in the loss of fluids and essential nutrients from the body.At present, there is a rise in the demand for enteric disease testing on account of the improper drainage and sanitation systems in various countries.
Global Enteric Disease Testing Market Trends:
The coronavirus disease (COVID-19) outbreak has increased the need for enteric disease testing across the globe to develop a potential treatment. In addition, the rising prevalence of bacterial disorders, such as intestine infections, polio, typhoid, E.coli and rotavirus,among the massesis propelling the market growth. Moreover, the growing cases of food and water-borne diseases worldwide are driving the market. Apart from this, initiatives undertaken by governments of numerous countries to organize webinars for spreading awareness about the benefits of regular monitoring of enteric disease are projected to stimulate the growth of the market in the upcoming years.
Request Free Sample Report:https://www.imarcgroup.com/enteric-disease-testing-market/requestsample
Global Enteric Disease Testing 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Bio-Rad Laboratories Inc.
- Biomerica Inc.
- Biomerieux SA
- Cepheid Inc. (Danaher Corporation)
- Coris BioConcept
- Meridian Bioscience Inc.
- Quest Diagnostics.
The report has segmented the market on the basis on region, product type, technique, disease type and end-user.
Breakup by Product Type:
- Reagents and Consumables
Breakup by Technique:
- Molecular Diagnostics
Breakup by Disease Type:
- Bacterial Enteric Disease
- Viral Enteric Disease
- Parasitic Enteric Disease
Breakup by End User:
- Hospital Diagnostic Laboratories
- Independent Diagnostic Laboratories
- Academic and Research Institutes
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=2544&flag=C
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Reports By IMARC Group
Plumbing Fixtures Market Share
Enteric Softgel Capsules Market Trends
Industrial Furnaces Market Report
Graphene Nanoplatelets Market Analysis
Inhaled Nitric Oxide Market Growth
Stretchable Conductive Material Market Size
Europe Electric Toothbrush Market Trends
Europe Natural Sweetener Market Report
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal